Francisco Epelde: Development and Validation of a Nomogram for Predicting Bleeding Risk in Patients with PE
Francisco Epelde, Attending Physician, internal Medicine Service at Parc Taulí University Hospital, posted on LinkedIn:
” ‘Development and Validation of a Nomogram for Predicting Bleeding Risk in Patients with Pulmonary Embolism’
DOI: 10.3389/fmed.2025.1692156
Authors: Tian Ye, Wanlin Lei, Maofeng Wang, Lili Xu
Read full article here or print here.
As Academic Editor, I had the privilege of overseeing this excellent study by Ye et al. (Wenzhou Medical University, China), which provides an important step toward personalized medicine in pulmonary embolism (PE) management.
Why this work matters:
Bleeding remains one of the most serious complications of anticoagulation therapy in PE. Current clinical scores—such as HAS-BLED or ATRIA—were not specifically developed for this population and often fail to capture the true hemorrhagic risk in acute PE settings.
This study overcomes that gap by developing and validating the first PE-specific bleeding risk nomogram, integrating six easily measurable clinical parameters: prior bleeding history, renal insufficiency, red blood cell count, systolic pressure, cerebral infarction, and creatinine.
Using data from 5,632 hospitalized patients, the model showed strong predictive performance (AUC 0.73–0.76) and was internally validated with excellent calibration. Importantly, decision curve analysis demonstrated clear clinical benefit—reducing major bleeding by up to 42% compared to standard care.
In essence, this paper exemplifies how data-driven tools can translate complex statistical modeling into bedside decision-making, supporting safer, more individualized anticoagulation strategies for patients with pulmonary embolism.”
Get insights from Hemostasis Today.
-
Sep 27, 2026, 13:31Mohamud Abdullahi Mohamed: Essential Resource for Clinical Hematology Diagnostics
-
Sep 27, 2026, 13:19Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment
-
Sep 27, 2026, 12:56Ana Lidia Flores-Mireles: Fibrin Suppresses Macrophage Defenses in Catheter-Associated UTIs
-
Sep 27, 2026, 12:30Francesco Onida: Maria Domenica Cappellini Receives 2026 Lettura Ferrata Award
-
Sep 27, 2026, 11:51Ashraf Dada: Smart Algorithm Enables Successful Single-Session Stem Cell Collection
-
Sep 27, 2026, 09:03Tareq Abadl: Hemoglobin Electrophoresis Patterns Across Thalassemia Syndromes
-
Sep 27, 2026, 08:33Vincent Serra: Beyond Oncology The Expanding Landscape of Immunotherapy
-
Sep 27, 2026, 08:18Tanmoy Debnath: Multiplexed Genetic Screening From a Single Newborn Blood Spot
-
Sep 27, 2026, 07:57Christopher D: Personalized CRISPR Therapy and the Future of Rare Disease Care